Daily Newsletter

21 November 2023

Daily Newsletter

21 November 2023

Manitoba pulls plug on diagnostic and surgical task force

The government now plans to focus on three projects, including the deployment of a mobile MRI service.

November 20 2023

The Manitoba government has dissolved the Diagnostic and Surgical Recovery Task Force (DSRTF) and is redirecting its focus and funding towards public health-care delivery.

This task force was set up in December 2021 to address wait-lists for diagnostic and surgical procedures and associated services hit by the COVID-19 crisis.

Shared Health, a provincial health organisation, will take on the management of the DSRTF structure as it is shut down.

Ongoing patient care and scheduled procedures will continue without interruption during this transition.

The government now plans to focus on three key projects to enhance public health care, including the deployment of a mobile MRI service in the Northern Regional Health Authority and the expansion of surgical slates at the Grace Hospital.

Besides, it aims to expand spinal surgery programmes at Brandon Regional Health Centre, Concordia Hospital, and Health Sciences Centre Winnipeg.

Minister of Health, Seniors and Long-Term Care Uzoma Asagwara said: “For the Grace Hospital, the addition of surgical slates for urology and arthroplasty means the community can expect enhanced surgical procedures, improved patient outcomes, and a higher standard of care.”

“This expansion will enable medical professionals to provide specialised treatments, addressing a broader range of medical needs within this community.

“We are excited about the positive impact this will have on the lives of patients and the overall well-being of the community.”

Northern Health Region vice-president medical services and chief medical officer Dr. Harsahil Singh said: “Having an MRI machine in northern Manitoba is going to be a huge step in bringing care closer to our patients and their loved ones, thereby reducing the need to travel large distances to receive this service in southern Manitoba.

“It will allow patients to get timely access to this important diagnostic tool. MRI enables clinicians to make critical clinical decisions that improves patient care, and we are excited to have this facility available in the north in the near future.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close